Senores Pharma IPO: The Rs 582 crore IPO of pharmaceutical company Senores Pharma Limited has received a strong response from investors. The issue was subscribed 93.69 times. According to data available with the National Stock Exchange, bids were placed for a total of 79,95,96,646 shares against the offer of 85,34,681 shares in the initial share sale. In the gray market, this IPO was trading at a premium of Rs 240 on December 25.

The company had raised about Rs 261 crore from anchor investors before the IPO opened. The price band for this IPO was fixed at Rs 372-391 per share. Its shares will be listed on BSE and NSE on December 30. The lot size of this IPO was 38 equity shares. To subscribe to this IPO, retail investors had to invest at least Rs 14,858.

Shares can be listed in the market at around Rs 631.
In the grey market, the company's shares are at a premium of 61 per cent over their issue price. At the current premium of Rs 240, the company's shares can be listed in the market at around Rs 631. The grey market is an unauthorized market where the shares of a company trade till its listing. According to market experts, investment decisions should be taken based on the business health of the company rather than the signals received from the grey market.

The company 's
business is mainly focused on the US, Canada and UK markets, while it has presence in emerging markets in 43 countries.